Study of the Role of Oncostatin M in Head and Neck Squamous Cell Carcinoma

NANot yet recruitingINTERVENTIONAL

Enrollment

119

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions

Head and Neck CancerCytokine

Interventions

OTHER

Biopsies and Blood collection

Each participant will have 2 additionnal biopsies during his/her diagnostic endoscopy plus two blood test during his/her inclusion

All Listed Sponsors

lead

Poitiers University Hospital

OTHER

NCT06199947 - Study of the Role of Oncostatin M in Head and Neck Squamous Cell Carcinoma | Biotech Hunter | Biotech Hunter